Grosfield Howard Exercises Stock Options at American Express
Grosfield Howard exercises stock options, increasing his stake in American Express, reflecting executive confidence in the finance services sector.
Artiva CEO Aslan Fred Sells Shares to Cover Tax Obligations
CEO Aslan Fred of Artiva Biotherapeutics sold shares to meet tax obligations, highlighting trends in executive compensation within the biotechnology sector.
Clement David P sells 4,800 shares of Vulcan Materials stock
Clement David P, SVP of Vulcan Materials, sold 4,800 shares of common stock, reflecting strategic management activity in the mining sector.
UnitedHealth Group Reports Strong Q3 Results Amid Growth
UnitedHealth Group's Q3 results show revenue growth and increased membership, reinforcing its leadership in the hospital and medical service plans sector.
Sixth Street Specialty Lending reports strong Q3 results
Sixth Street Specialty Lending, Inc. announces its Q3 financial results, showcasing growth and stability in the specialty lending sector.
Banerjee Subhashis sells shares to cover tax obligations
Banerjee Subhashis, CMO of Artiva Biotherapeutics, sells shares to meet tax obligations, reflecting executive activity in the life sciences sector.
SLM Corp CFO Graham Peter M Reports Stock Transaction
Graham Peter M, CFO of SLM Corp, disclosed a stock transaction involving over 10,000 shares, emphasizing the company's executive compensation strategy.
Versant Media Group reports third-quarter results for 2026
Versant Media Group, Inc. shares its third-quarter results for 2026, highlighting growth in the television broadcasting sector amid industry changes.
Vertex Pharmaceuticals Reports Q3 2026 Financial Results
Vertex Pharmaceuticals has filed its Q3 2026 report, detailing significant financial metrics and ongoing projects in the pharmaceutical sector.
Transcat Inc. reports quarterly results, shows industry strength
Transcat Inc. has released its quarterly report, showcasing its performance in the measurement instruments sector and highlighting growth potential.
Sotera Health reports Q3 results, outlines future strategies
Sotera Health Co releases its Q3 financial results, detailing growth strategies and operational updates that impact the health services industry.
Bilibili schedules board meeting for Q3 2026 results approval
Bilibili Inc. announces board meeting on November 24, 2026, to approve Q3 2026 financial results, highlighting its commitment to transparency.
Arvinas reports Q3 results with updates on collaborations
Arvinas, Inc. releases its Q3 2026 report, highlighting financial performance and collaborations with Pfizer and Rigel Pharmaceuticals.
Nurix Therapeutics announces Sanofi halting SAR448272 trial
Nurix Therapeutics faces a setback as Sanofi discontinues its SAR448272 clinical trial, impacting future milestone payments and collaboration strategy.
Manitowoc Company reports Q3 2026 earnings results
Manitowoc Company announces its Q3 2026 earnings, highlighting key financial metrics and implications for the construction machinery industry.
Transcat Reports Strong Q2 Results with Revenue Growth
Transcat Inc. announces strong Q2 fiscal 2027 results, showcasing significant revenue growth and margin expansion, indicating robust performance in the testing instruments industry.
Denali Therapeutics Reports Strong Q3 2026 Financial Results
Denali Therapeutics Inc. announces robust Q3 2026 results, driven by AVLAYAH revenue growth and positive market response, signaling strong industry momentum.
Axos Financial unveils new investor presentation strategy
Axos Financial, Inc. announces a new investor presentation, showcasing its strategies and performance metrics, effective November 4, 2026.
Gladstone Commercial reports Q3 results with revenue decline
Gladstone Commercial Corp announces a decrease in total operating revenue for Q3 2026, reflecting ongoing challenges in the real estate sector.
Curaleaf Reports Record Third Quarter Revenue and Profitability
Curaleaf Holdings, Inc. announces impressive third-quarter results with record revenue of $353 million, demonstrating strong growth in the medicinal cannabis sector.